Stereotaxis, Inc. Common Stock (STXS)

Stereotaxis stock fell sharply after Q3 2025 results, as a 13% revenue miss overshadowed a smaller-than-expected quarterly loss.

Stereotaxis (AMEX: STXS) announces first procedures with Genesis Robotic Magnetic Navigation System for minimally invasive endovascular interventions.

Stereotaxis Inc (NYSE:STXS) Q2 2025 earnings beat revenue estimates with $8.8M, narrowing losses to -$0.05 EPS. Stock rose 1.83% post-announcement.

Stereotaxis shares are moving higher on Wednesday after the company announced it was accepted into the NVIDIA Connect program.

STXS stock results show that Stereotaxis missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

STXS stock results show that Stereotaxis met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here.

These seven penny stocks to buy have the potential to 5X your money by the end of 2024 if the right catalysts unfold.

Although lesser-known ideas present high risks, these cheap stocks under $10 could be intriguing for the calculating speculator.

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.